avatar
kevin# Stock
l*m
1
http://people.forbes.com/profile/kevin-c-tang/7142
Mr. Kevin C. Tang founded Tang Capital Management, LLC in August 2002 and
has been its Managing Director since August 2002. Mr. Tang held various
positions at Deutsche Banc Alex. Brown, Inc., an investment banking firm
from September 1993 to July 2001 and also served as Managing Director and
Head of the Life Sciences research group. He served as Chairman of Penwest
Pharmaceuticals Co. until September 20, 2010 and also as its Director from
June 2009 to September 20, 2010. He serves as a Director of RXi
Pharmaceuticals. Mr. Tang has been an Independent Director of AP Pharma Inc.
since February 2009. He has been a Director of CoreLab Partners, Inc. (a/k/
a Radpharm, Inc.) since March 1, 2006 and Aclara Biosciences Inc. since
November 2002. Mr. Tang serves as a Director of Ambit Biosciences
Corporation. He has been a Director of Ardea Biosciences, Inc. since May
2003. He served as a Director of Senomyx Inc. He served as a Director of
Intrabiotics Pharmaceuticals Inc. since May 2003. Mr. Tang served as a
Director of Trimeris Inc. from August 2001 to December 2008. Mr. Tang
received his B.S. degree from Duke University.
avatar
w*2
2
orz

Inc.
k/

【在 l*********m 的大作中提到】
: http://people.forbes.com/profile/kevin-c-tang/7142
: Mr. Kevin C. Tang founded Tang Capital Management, LLC in August 2002 and
: has been its Managing Director since August 2002. Mr. Tang held various
: positions at Deutsche Banc Alex. Brown, Inc., an investment banking firm
: from September 1993 to July 2001 and also served as Managing Director and
: Head of the Life Sciences research group. He served as Chairman of Penwest
: Pharmaceuticals Co. until September 20, 2010 and also as its Director from
: June 2009 to September 20, 2010. He serves as a Director of RXi
: Pharmaceuticals. Mr. Tang has been an Independent Director of AP Pharma Inc.
: since February 2009. He has been a Director of CoreLab Partners, Inc. (a/k/

相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。